Stock Events

Stock Events

Larimar Therapeutics (ZA71.STU) Q2 2026 Earnings

14MayConfirmed

Q2 2026

-0.46

-0.39

-0.33

-0.27

Details

Expected EPS

-0.4582680004

Actual EPS

-0.26576299999999997

Surprise EPS

0.19

Surprise Percent

+42.01%

Description

Larimar Therapeutics (ZA71.STU) has reported earnings of -0.26576299999999997 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.